Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir-based DAA Therapy for HIV/HCV Coinfected Patients
NCT02533934Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Aug 2016
- Primary completion
- Dec 2019
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of Harvoni in hepatitis C (HCV), sponsored by University of California, San Francisco. Started Aug 2016; status: completed.
02
Drugs
Harvoni
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02533934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02533934.